Marc Pourrier

The new antiarrhythmic drug vernakalant: ex vivo study of human atrial tissue from sinus rhythm and chronic atrial fibrillation.

Ursula Ravens, Erich Wettwer, Torsten Christ, 2013, Cardiovascular research.

Comparison of electrophysiological and antiarrhythmic effects of vernakalant, ranolazine, and sotalol in canine pulmonary vein sleeve preparations.

Charles Antzelevitch, C. Antzelevitch, S. Sicouri, 2012, Heart rhythm.

Rate-Dependent Effects of Vernakalant in the Isolated Non-Remodeled Canine Left Atria Are Primarily Due to Block of the Sodium Channel: Comparison With Ranolazine and dl-Sotalol

John K. Gibson, Joseph J. Lynch, Charles Antzelevitch, 2012, Circulation. Arrhythmia and electrophysiology.

Kir2.4 and Kir2.1 K+ channel subunits co‐assemble: a potential new contributor to inward rectifier current heterogeneity

Stanley Nattel, Peter Melnyk, S. Nattel, 2002, The Journal of physiology.

Differential Distribution of Cardiac Ion Channel Expression as a Basis for Regional Specialization in Electrical Function

Stanley Nattel, Peter Melnyk, S. Nattel, 2002, Circulation research.